AWS has partnered with EvolutionaryScale to introduce its cutting-edge language models for biology to researchers and scientists in various fields such as drug discovery and carbon capture. The collaboration will make EvolutionaryScale’s ESM3 models available on AWS, enabling researchers to create new proteins and streamline the process of bringing new therapies to market. These models can be accessed through Amazon SageMaker and AWS HealthOmics for automated drug discovery workflows.
AWS is leading the way in promoting generative AI in life sciences, offering easy access to high-performance models through Amazon Rock and Amazon SageMaker. This technology is transforming research processes in industries like pharmaceuticals, with companies like AstraZeneca, Gilead, and Pfizer using AI solutions to accelerate drug discovery and save costs. The collaboration with EvolutionaryScale aims to revolutionize research and development for life sciences customers by providing advanced generative language models for biology.
EvolutionaryScale’s ESM3 models offer breakthrough capabilities in generating novel proteins designed for various applications in healthcare and biotechnology. These models leverage billions of years of protein sequence data to create entirely new proteins that have never existed in nature. Customers can access and fine-tune ESM3 through AWS services like Amazon SageMaker and AWS HealthOmics, ensuring privacy and security in their research endeavors.
AWS’s collaboration with EvolutionaryScale marks a new chapter in AI-powered generative models for biology, with ESM3 poised to accelerate drug discovery timelines and revolutionize therapeutic development. By combining AWS’s infrastructure and generative AI capabilities with EvolutionaryScale’s innovative models, researchers can push the boundaries of science and deliver novel therapies faster and more effectively. The responsible use of generative AI ensures that advancements in drug development are achieved ethically and transparently, driving innovation and success in the field of biology.
Article Source
https://aws.amazon.com/blogs/industries/revolutionizing-generative-biology-with-aws-and-evolutionaryscale/